| Literature DB >> 30674655 |
Guillaume Canaud1,2,3, Craig R Brooks1,4, Seiji Kishi1,5, Kensei Taguchi4, Kenji Nishimura5, Sato Magassa2, Adam Scott1,6, Li-Li Hsiao1, Takaharu Ichimura1, Fabiola Terzi2, Li Yang7, Joseph V Bonventre8,9,10.
Abstract
Fibrosis contributes to the progression of chronic kidney disease (CKD). Severe acute kidney injury can lead to CKD through proximal tubular cell (PTC) cycle arrest in the G2-M phase, with secretion of profibrotic factors. Here, we show that epithelial cells in the G2-M phase form target of rapamycin (TOR)-autophagy spatial coupling compartments (TASCCs), which promote profibrotic secretion similar to the senescence-associated secretory phenotype. Cyclin G1 (CG1), an atypical cyclin, promoted G2-M arrest in PTCs and up-regulated TASCC formation. PTC TASCC formation was also present in humans with CKD. Prevention of TASCC formation in cultured PTCs blocked secretion of profibrotic factors. PTC-specific knockout of a key TASCC component reduced the rate of kidney fibrosis progression in mice with CKD. CG1 induction and TASCC formation also occur in liver fibrosis. Deletion of CG1 reduced G2-M phase cells and TASCC formation in vivo. This study provides mechanistic evidence supporting how profibrotic G2-M arrest is induced in kidney injury and how G2-M-arrested PTCs promote fibrosis, identifying new therapeutic targets to mitigate kidney fibrosis.Entities:
Mesh:
Substances:
Year: 2019 PMID: 30674655 PMCID: PMC6527117 DOI: 10.1126/scitranslmed.aav4754
Source DB: PubMed Journal: Sci Transl Med ISSN: 1946-6234 Impact factor: 17.956